ESMO Symposium on Signalling Pathways in Cancer 2018

Cyclin-dependent kinases (CDKs)

Barcelona, Spain - 23 Mar - 24 Mar 2018

The 6th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), focused on Cyclin-dependent kinases (CDKs).

It was the next important step in a strategic collaboration between basic scientists and translational and clinical researchers. The aim was to foster close cooperation among academics, clinical and industry researchers in a highly interactive hands-on professional environment.

The Scientific Committee was composed of some of the world’s leading experts in modern cancer medicine. They worked together to ensure you learn and discuss the most advanced approaches known to us today.

ESMO Scientific Co-Chair

  • Josep Tabernero, Barcelona, Spain

EACR Scientific Co-Chair

  • Alberto Bardelli, Turin, Italy

Scientific Committee

  • Fabrice André, Villejuif, France
  • Giuseppe Curigliano, Milan, Italy
  • Clare Isacke, London, UK
  • Joan Seoane, Barcelona, Spain

In collaboration with

vall-hebron-logo